It showed that EIF3B was more highly expressed in breast cancer tissues than matched paraneoplastic tissues and more highly expressed in tissues of high pathological grade than those of low pathological grade (Figures 5(g) and 5(i)), which was consistent with the trend of mRNA expression in tissues from breast cancer patients (Figure 5(j-k)). This evidence concerns the gene EIF3B and breast cancer.